Racial Disparity Seen in Prescriptions for Buprenorphine
Office visits for drug to treat opioid use disorder most commonly self-pay or private insurance
Read MoreMay 20, 2019
Office visits for drug to treat opioid use disorder most commonly self-pay or private insurance
Read MoreMay 16, 2019
PARIS (Reuters) – Opioid use has reached crisis proportions not only in the United States but also in Canada and some European countries, as prescription opioid painkillers have become much more common, the OECD club of...
Read MoreMay 14, 2019
By Lisa Rapaport (Reuters Health) – While the number of Americans getting drug treatment for opioid addiction is on the rise, a new study suggests that gains may be concentrated among white patients and people who can pay...
Read MoreMay 13, 2019
16.9 percent of workers with any low back pain missed at least one day of work in previous three months
Read MoreMay 10, 2019
By Julie Steenhuysen INDIANAPOLIS (Reuters) – Eli Lilly and Co has pulled ahead in a...
Read MoreMay 9, 2019
By Linda Carroll (Reuters Health) – In states where pharmacists were allowed to sell the...
Read MoreMay 3, 2019
By Linda Carroll (Reuters Health) – A tiny percentage of people at high risk for opioid overdose are getting prescriptions for naloxone, a medication that could potentially save their lives, a new study finds. Researchers...
Read MoreMay 2, 2019
By Nate Raymond BOSTON (Reuters) – The founder of Insys Therapeutics Inc on Thursday became...
Read MoreMay 2, 2019
By Nate Raymond (Reuters) – Drug distributor McKesson Corp has agreed to pay $37 million to...
Read MoreMay 1, 2019
By Manas Mishra (Reuters Health) – Teens with painful chronic illnesses may find that...
Read MoreMay 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Gender Differences Seen in Adverse Drug Reactions FRIDAY, […]
Read MoreMay 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Gender Differences Seen in Adverse Drug Reactions […]
Read MoreApr 23, 2019
By Manas Mishra (Reuters) – Teva Pharmaceutical Industries Ltd said on Tuesday it would stop...
Read MoreApr 19, 2019
(Reuters) – Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval...
Read MoreApr 19, 2019
But there may be a higher stroke risk in elderly patients with diabetes taking the drug
Read MoreApr 18, 2019
By Manas Mishra and Tamara Mathias (Reuters) – U.S. health officials on Thursday said they...
Read MoreApr 18, 2019
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and...
Read MoreApr 18, 2019
Early physical therapy (PT) may help reduce the risk of long-term opioid use by serving as an...
Read MoreApr 18, 2019
Individuals linked to about 350,000 prescriptions and 32 million pills
Read MoreApr 17, 2019
By Gabriella Borter (Reuters) – Dozens of medical professionals in Appalachia, a region...
Read More